Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2025)
Nurix Therapeutics (NRIX) reported Tax Provisions of $760000.0 for Q2 2025, up 744.44% year-over-year from $90000.0 in Q2 2024, and up 9400.0% quarter-over-quarter from $8000.0 in Q4 2024.
Nurix Therapeutics (NRIX) Tax Provisions (2019 - 2025) Analysis & Trends
Nurix Therapeutics (NRIX) has 5 years of Tax Provisions data on file, last reported at $760000.0 in Q2 2025.
- Tax Provisions for Q2 2025 came in at $760000.0, up 744.44% year-over-year; the trailing twelve-month figure through Nov 2025 was $760000.0 (up 181.48% YoY), and the FY2025 annual result was $760000.0, up 181.48% from the prior year.
- Tax Provisions rose to $760000.0 in Q2 2025 per NRIX's latest filing, from $8000.0 in the prior quarter.
- Over five years, Tax Provisions peaked at $760000.0 in Q2 2025 and troughed at -$123000.0 in Q3 2021.
- A 3-year average of $124666.7 and a median of $82000.0 in 2024 frame the typical range for Tax Provisions.
- The sharpest annual moves came in 2021 and 2025: Tax Provisions surged 91.3% in 2021, then surged 744.44% in 2025.
- A 3-year view of Tax Provisions shows it stood at $44000.0 in 2021, then sank by 81.82% to $8000.0 in 2024, then jumped by 9400.0% to $760000.0 in 2025.
- Business Quant data shows NRIX's Tax Provisions at $760000.0 in Q2 2025, $8000.0 in Q4 2024, and $82000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Nurix Therapeutics | 1.93 Bn | 1.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2025 | 760,000.00 |
| Nov 30, 2024 | 8,000.00 |
| Aug 31, 2024 | 82,000.00 |
| May 31, 2024 | 90,000.00 |
| Feb 29, 2024 | 90,000.00 |
| Nov 30, 2021 | 44,000.00 |
| Aug 31, 2021 | -123,000.00 |
| May 31, 2021 | 100,000.00 |
| Feb 28, 2021 | 71,000.00 |
| Nov 30, 2020 | 23,000.00 |
| May 31, 2020 | -20.59 Mn |
| Feb 29, 2020 | 11,000.00 |
| Nov 30, 2019 | 171,000.00 |
| Aug 31, 2019 | 10,000.00 |